These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9661006)

  • 1. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata.
    Miyazaki H; Miyazaki Y; Geber A; Parkinson T; Hitchcock C; Falconer DJ; Ward DJ; Marsden K; Bennett JE
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1695-701. PubMed ID: 9661006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
    Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.
    Moran GP; Sanglard D; Donnelly SM; Shanley DB; Sullivan DJ; Coleman DC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1819-30. PubMed ID: 9661028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
    Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.
    Vermitsky JP; Edlind TD
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3773-81. PubMed ID: 15388433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.
    Sanglard D; Ischer F; Bille J
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1174-83. PubMed ID: 11257032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function of Candida glabrata ABC transporter gene, PDH1.
    Izumikawa K; Kakeya H; Tsai HF; Grimberg B; Bennett JE
    Yeast; 2003 Feb; 20(3):249-61. PubMed ID: 12557277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
    Gohar AA; Badali H; Shokohi T; Nabili M; Amirrajab N; Moazeni M
    Mycopathologia; 2017 Apr; 182(3-4):273-284. PubMed ID: 27744635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei.
    Katiyar SK; Edlind TD
    Med Mycol; 2001 Feb; 39(1):109-16. PubMed ID: 11270397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants.
    Tsai HF; Krol AA; Sarti KE; Bennett JE
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1384-92. PubMed ID: 16569856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
    Borst A; Raimer MT; Warnock DW; Morrison CJ; Arthington-Skaggs BA
    Antimicrob Agents Chemother; 2005 Feb; 49(2):783-7. PubMed ID: 15673768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with In Vivo Persistence.
    Ben-Ami R; Zimmerman O; Finn T; Amit S; Novikov A; Wertheimer N; Lurie-Weinberger M; Berman J
    mBio; 2016 Aug; 7(4):. PubMed ID: 27486188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole.
    Niimi M; Nagai Y; Niimi K; Wada Si; Cannon RD; Uehara Y; Monk BC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Dec; 782(1-2):245-52. PubMed ID: 12458010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
    Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
    J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.